==External links==
*Dr Orla O'Donovan, "[http://www.crida-fr.org/03_actualites/streams/stream%206/ISTR%20paper%20-%20version%202.doc Time to weed out the astroturf from the grassroots? Exploring the implications of pharmaceutical industry funding of patients’ advocacy organisations]", Paper presented at Concepts of the Third Sector: The European Debate , ISTR/EMES Conference, Paris , 27-29 April 2005.
*Dr Orla O'Donovan, "[http://www.ucc.ie/en/DepartmentsCentresandUnits/AppliedSocialStudies/Staff/AcademicStaff/DrOrlaODonovan/ Current Research]", Accessed July 2006.
*Thomas Ginsberg, "[http://www.philly.com/mld/inquirer/14687073.htm Donations tie drug firms and nonprofits: Many patient groups reveal few, if any, details on relationships with pharmaceutical donors]", ''Philadelphia Inquirer'', May 28, 2006.
*Reed Abelson, "[http://www.nytimes.com/2006/06/28/business/28foundation.html?_r=1&adxnnl=1&oref=slogin&adxnnlx=1151553743-sljrvFovoMv7eiGnYP9hDw Charities Tied to Doctors Get Drug Industry Gifts]", ''New York Times'', June 28, 2006.
*Jo Revill, "[http://observer.guardian.co.uk/uk_news/story/0,,1810829,00.html Cancer drug firm's PR trip sparks a row:] MPs and charity officials defend paid-for visit to see 'gold standard' treatment at French hospital", ''The Observer'', July 2, 2006.
[[Category:Health]][[Category:Pharmaceutical industry]]